VistaGen Therapeutics Inc. (VTGN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    VistaGen Therapeutics Inc...

    NASDAQ: VTGN · Real-Time Price · USD
    3.53
    0.16 (4.75%)
    At close: Sep 26, 2025, 3:59 PM
    3.53
    0.00%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    VistaGen Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Net Income
    		 -51.42M -29.36M -59.25M -47.76M -17.93M
    Depreciation & Amortization
    		 635K 568K 509.8K 711.1K 117.6K
    Stock-Based Compensation
    		 4.32M 2.18M 3.34M 3.48M 2.31M
    Other Working Capital
    		 -921K 271K 2.96M -1.69B 3.48M
    Other Non-Cash Items
    		 -389K 6K -929.14M 232K 2.53M
    Deferred Income Tax
    		 n/a n/a 932.8M n/a -2.53M
    Change in Working Capital
    		 4.76M 793K 2.03M -1.92M 3.44M
    Operating Cash Flow
    		 -42.1M -25.81M -49.72M -45.26M -12.07M
    Capital Expenditures
    		 -191K -61K -212K -200.4K -275.4K
    Cash Acquisitions
    		 n/a n/a -528.3K n/a n/a
    Purchase of Investments
    		 -24.98M n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 12.03M n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 -13.15M -61K -740.3K -200.4K -275.4K
    Debt Repayment
    		 n/a -985K -1.04M -3K -382K
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a -945.1M -1.39B
    Other Financial Acitivies
    		 201K 8K n/a 951.15M 1.39B
    Financial Cash Flow
    		 3.21M 128.4M -1.04M 10.48M 114.1M
    Net Cash Flow
    		 -52.03M 102.53M -51.5M -34.97M 101.75M
    Free Cash Flow
    		 -42.29M -25.87M -49.93M -45.46M -12.35M

    Add to Watchlist